---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-020806"
form_type: "8-K"
ticker: "NUVL"
cik: "0001861560"
company_name: "Nuvalent, Inc."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T04:55:56.415355+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nuvalent reports Q1 2023 net loss of $25.2M; NVL-655 Phase 1 data expected H2 2023

## Summary
- Net loss of $25.2M ($0.44 per share) for Q1 2023.
- Cash, cash equivalents and marketable securities of $450.5M; runway into H2 2025.
- R&D expenses $22.1M, G&A expenses $8.1M for Q1 2023.
- Preliminary dose-escalation data for NVL-655 (ALK inhibitor) from ALKOVE-1 trial expected H2 2023.
- NVL-520 (ROS1) Phase 1 enrollment ongoing; NVL-330 (HER2) in IND-enabling studies.

## SEC filing metadata
- accession: 0000950170-23-020806
- form_type: 8-K
- ticker: NUVL
- cik: 0001861560
- company_name: Nuvalent, Inc.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861560/000095017023020806/0000950170-23-020806-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861560/000095017023020806/nuvl-20230511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-020806
- JSON: https://secwatch.observer/filing/0000950170-23-020806.json
- Plain text: https://secwatch.observer/filing/0000950170-23-020806.txt

## Key facts
- Earnings Releases
  Nuvalent, Inc. reported the first quarter of 2023 results: net income Net loss for the first quarter of 2023 was $25.2 million, EPS $0.44 per share.
  - Period: the first quarter of 2023
  - Net income: Net loss for the first quarter of 2023 was $25.2 million
  - EPS: $0.44 per share
  - Result: reported results
  source text: Net loss for the first quarter of 2023 was $25.2 million, or $0.44 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861560/000095017023020806/0000950170-23-020806-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.